Work

Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal Adenocarcinoma from Type 2 Diabetes

Year: 2023

Type: article

Study design: Observational Study

Source: Clinica Chimica Acta

DOI: 10.1016/j.cca.2023.117567

Authors: Seetharaman Balasenthil, Suyu Liu, Jianliang Dai, William R. Bamlet, Gloria Petersen, Suresh T Chari, Anirban Maitra, Nanyue Chen, Subrata Sen, Ann McNeill Killary

Institutions: The University of Texas MD Anderson Cancer Center, Mayo Clinic

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: G5014124621, Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer, Clinical Validation Center for Early Detection of Pancreatic Cancer

OpenAlex ID: W4387096310

FWCI: 0.352

Cites: 26

Cited by: 3

Related to: 10